Balkhiyarova, Z.,
Luciano, R.,
Kaakinen, M.,
Ulrich, A.,
Shmeliov, A.,
Bianchi, M.,
Chioma, L.,
Dallapiccola, B.,
Prokopenko, I.,
Manco, M. (2022) part of the genetic background. We aimed to
test if weighted genetic risk scores (GRSs) for T2D
.
Functional soft azo dye compounds exhibiting distinct
functionalities in response to polarized light
Kudoyarov, E.R.,
Karimov, D.O.,
Bakirov, A.B.,
Mukhammadieva, G.F.,
Karimova, L.K.,
Galimova, R.R. (2022) obtained by
tests that included indicator enzyme identification, and DNA damage. Following the study
Qian, J.,
Zhuang, F.,
Chen, Y.,
Fan, X.,
Wang, J.,
Wang, Z.,
Wang, Y.,
Xu, M.,
Samorodov, A.V.,
Pavlov, V.N.,
Liang, G. (2022) in DCM and to
test the therapeutic effects of MD2 inhibitor C30 on DCM. Streptozotocin (STZ) was used